ArticleDrug testing and analysis2025
Sports Supplement Analysis Survey for the Prevalence of WADA Prohibited Substances in the Australian Online Marketplace.
Article in Drug testing and analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Annual Banned-Substance Review 18th Edition-Analytical Approaches in Human Sports Drug Testing 2024/2025.Drug testing and analysis · 2026Review
- Systematic review of undeclared prohibited substances and pharmacological adulterants in dietary supplements: prevalence, detection, and risks in sport.Frontiers in sports and active living · 2026Review
- Gender Differences in Anti-Doping Rule Violations Based on a 19-Year Data Analysis from the Serbian Anti-Doping Agency: National Study.Sports (Basel, Switzerland) · 2025Article
- Sports Supplement Analysis Survey for the Prevalence of WADA Prohibited Substances in the Australian Online Marketplace.Drug testing and analysis · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Sports supplements are used extensively by people involved in competitive sports. However, a proportion of sports supplements contain World Anti-Doping Agency (WADA) Prohibited Substances, which have the potential to cause an anti-doping rule violation (ADRV). In 2022, Sport Integrity Australia (SIA) contracted Human and Supplements Testing Australia (HASTA) to purchase and analyse 200 sports supplement products available in the Australian online marketplace. The aim of the survey was to determine the likelihood of purchasing a product containing one or more WADA Prohibited Substances. Of the 200 products purchased, 35% contained WADA Prohibited Substances, with the majority of these findings being stimulants. Products marketed as pre-workouts, fat burners and muscle builders were the most likely to contain prohibited substances. It is notable that 83% of the WADA Prohibited Substances detected were naturally occurring compounds; only two of the products contained high levels of synthetic stimulants. Fifty-seven percent of the products that contained WADA Prohibited Substances did not have the substances labelled as ingredients on the packaging or website. Athlete education concerning sports supplements should remain a high priority, with a prevalence rate of approximately one in three products purchased containing WADA Prohibited Substances. To reduce the risk of an inadvertent ADRV, if an athlete wishes to use sports supplements, they should consult with their medical practitioner or accredited sports dietician (ASD) as to whether they require them and, if so, only take products that have been independently tested.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.